Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously

NCT00788294 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
76
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer